Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate whether Osmotic-Release Methylphenidate (OROS
MPH), relative to placebo, increases the effectiveness of standard smoking treatment (i.e.,
nicotine patch and individual smoking cessation counseling) in obtaining prolonged abstinence
for smokers with Attention Deficit Hyperactivity Disorder (ADHD).
Phase:
Phase 3
Details
Lead Sponsor:
University of Cincinnati
Collaborators:
National Institute on Drug Abuse (NIDA) Ortho-McNeil Janssen Scientific Affairs, LLC